RNAC Operating Expenses

Cartesian Therapeutics Inc · Operating Expenses

RNAC logo

RNAC Operating Expenses

Latest reported$29.16M
RNAC Quarterly Operating Expenses ($6.84M → $29.16M)
High-resolution chart · PNG

RNAC operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cartesian Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
29,155,000
26,577,000
22,886,000
8,721,000
22,109,000
22,989,000
25,972,000
17,962,000
19,688,000
19,188,000
44,598,000
6,614,000
6,105,000
5,695,000
24,684,000
21,770,000
24,915,000
22,582,000
25,859,000
26,396,000
19,211,000
18,208,000
19,849,000
18,380,000
16,367,000
18,822,000
19,224,000
11,794,000
16,248,000
11,866,000
15,402,000
15,941,000
18,769,000
15,813,000
19,294,000
13,881,000
15,897,000
14,919,000
16,790,000
8,516,000
8,418,000
9,029,000
9,241,000
7,678,000
7,552,000
6,844,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.